首页|细胞因子信号传导抑制蛋白1在鼻咽癌中的表达及临床价值

细胞因子信号传导抑制蛋白1在鼻咽癌中的表达及临床价值

扫码查看
目的 探讨细胞因子信号传导抑制蛋白1在鼻咽癌中的表达及价值.方法 选取2019年6月至2023年12月我院收治的69例手术切除的鼻咽癌组织和对应癌旁组织作为研究对象,采用蛋白质免疫印迹和荧光定量PCR分析细胞因子信号传导抑制蛋白1表达水平;分析细胞因子信号传导抑制蛋白1表达水平与鼻咽癌组织KI67和PCNA阳性率的关系.并分析细胞因子信号传导抑制蛋白1表达水平与鼻咽癌患者临床病理特征与预后的诊断价值.组间比较采用独立样本t检验.结果 鼻咽癌组织细胞因子信号传导抑制蛋白1 mRNA和蛋白质表达水平(0.64±0.15、0.54±0.16)明显低于癌旁组织(1.04±0.14、0.93±0.19),差异有统计学意义(t=15.830、12.710,P<0.05).Ki-67和PCNA阳性患者细胞因子信号传导抑制蛋白1表达水平(0.48±0.12、0.47±0.12)明显低于Ki-67和PCNA阳性患者鼻咽癌组织(0.74±0.09、0.70±0.11),差异有统计学意义(t=7.531、7.310,P<0.05).未分化型癌患者鼻咽癌组织细胞因子信号传导抑制蛋白1表达水平(0.46±0.15)明显低于分化型非角化癌患者(0.59±0.13),差异有统计学意义(t=3.579,P<0.05).低分化型癌患者鼻咽癌组织细胞因子信号传导抑制蛋白1表达水平(0.44±0.14)明显低于中高分化患者(0.63±0.11),差异有统计学意义(t=5.216,P<0.05).Ⅲ~Ⅳ期患者鼻咽癌组织细胞因子信号传导抑制蛋白1表达水平(0.43±0.13)明显低于中高分化患者(0.62±0.12),差异有统计学意义(t=4.876,P<0.05).高表达组鼻咽癌患者生存时间[(20.36±4.71)个月]明显高于低表达组患者[(15.80±4.59)个月],差异有统计学意义(Log-Rank=6.201,P<0.05).细胞因子信号传导抑制蛋白1预测鼻咽癌预后不良的曲线下面积为0.845,特异性为75.63%,敏感度为81.54%.高TNM分期和细胞因子信号传导抑制蛋白1低表达是鼻咽癌预后不良的独立危险因素(P<0.05).结论 细胞因子信号传导抑制蛋白1在鼻咽癌组织中低表达,是鼻咽癌预后不良的主要因素.
Expression and clinical value of cytokine signaling inhibitor 1 in nasopharyngeal carcinoma
Objective To explore the expression and value of cytokine signaling inhibitor 1 in na-sopharyngeal carcinoma.Methods A total of 69 cases of nasopharyngeal carcinoma tissues and corre-sponding adjacent tissues from our hospital from June 2019 to December 2023 selected as the research sub-jects.The expression level of cytokine signaling inhibitor 1 was analyzed by Western blotting and fluores-cence quantitative PCR.The relationship between the expression level of inhibitor of cytokine signaling pro-tein 1 and the positive rate of Ki-67 and PCNA in nasopharyngeal carcinoma tissues was analyzed.The di-agnostic value of the expression level of inhibitor of cytokine signaling protein 1 and the clinicopathological characteristics and prognosis of patients with nasopharyngeal carcinoma was analyzed.The measurement da-ta between groups were compared by independent sample t test.Results The expression levels of inhibitor of cytokine signaling protein 1 mRNA and protein in nasopharyngeal carcinoma tissues(0.64±0.15,0.54±0.16)were significantly lower than those in adjacent tissues(1.04±0.14,0.93±0.19,t=15.830,12.710,P<0.05).The expression level of inhibitor of cytokine signaling protein 1 in Ki-67 and PCNA positive patients(0.48±0.12,0.47±0.12)was significantly lower than that in nasopharyngeal carcinoma tissues of Ki-67 and PCNA positive patients(0.74±0.09,0.70±0.11,t=7.531,7.310,P<0.05).The expression level of inhibitor of cytokine signaling protein 1 in nasopharyngeal carcinoma tissues of pa-tients with undifferentiated carcinoma(0.46±0.15)was significantly lower than that of patients with dif-ferentiated non keratinizing carcinoma(0.59±0.13,t=3.579,P<0.05).The expression level of inhib-itor of cytokine signaling protein 1 in nasopharyngeal carcinoma tissues of patients with poorly differentiated carcinoma(0.44±0.14)was significantly lower than that of patients with moderately well differentiated carcinoma(0.63±0.11,t=5.216,P<0.05).The expression level of inhibitor of cytokine signaling pro-tein 1 in nasopharyngeal carcinoma tissues of stage Ⅲ-Ⅳ patients(0.43±0.13)was significantly lower than that of patients with medium to high differentiation(0.62±0.12,t=4.876,P<0.05).The survival time of patients in the high expression group[(20.36±4.71)months]was significantly higher than that of patients in the low expression group[(15.80±4.59)months,log rank=6.201,P<0.05].The area un-der the curve of inhibitory protein of cytokine signaling 1 predicting the poor prognosis of nasopharyngeal carcinoma was 0.845.The specificity was 75.63%,and the sensitivity was 81.54%.High TNM stage and low expression of inhibitor of cytokine signaling protein 1 were independent risk factors for poor prognosis of nasopharyngeal carcinoma(P<0.05).Conclusion The low expression of inhibitor of cytokine signaling protein 1 in nasopharyngeal carcinoma is the main factor of poor prognosis of nasopharyngeal carcinoma.

Cytokine signaling inhibitory protein 1Nasopharyngeal carcinomaClinicopatho-logical featuresPrognosis

白璐月、朱运华

展开 >

商丘市第一人民医院(徐州医科大学临床学院)耳鼻喉头颈外科,商丘 476000

细胞因子信号传导抑制蛋白1 鼻咽癌 临床病理特征 预后

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(11)